Table 1.
Baseline characteristics for carrier of the FRAX premutation and the FRAX mutation
| All patients (n = 30) Median [IQ] | FRAX premutation (n = 18) Mean (SD) |
FRAX full mutation (n = 12) Mean (SD) | p value | |
|---|---|---|---|---|
| Woman age at 1st PGD cycle (years) | 32.5 [22–40] | 31.0 (4.7) | 33.3 (4.4) | 0.1609 |
| Man age at 1st PGD cycle (years) | 35 [22–45] | 32.5 (6.6) | 36.1 (6.0) | 0.1372 |
| Woman BMI at 1st PGD cycle (kg/m2) | 21.3 [18.7–32.1] | 21.9 (3.2) | 23.8 (3.9) | 0.2358 |
| Serum AMH at 1st PGD cycle (ng/mL) | 1.9 [0.27–9.6] | 1.9 (1.3) | 4.0 (2.6) | 0.0167 |
| Serum E2 at D3 at 1st PGD cycle (pg/mL) | 42 [12–118] | 38.9 (24.3) | 45.8 (11.9) | 0.0537 |
| Serum FSH at D3 at 1st PGD cycle (IU/L) | 7.3 [2.9–20.4] | 8.1 (3.5) | 6.6 (1.9) | 0.2192 |
| AFC at 1st PGD cycle | 13 [5–33] | 13.7 (5.5) | 17.4 (7.5) | 0.1889 |
| Cycle duration (days) | 28 [24–33] | 28.2 (1.9) | 28.0 (2.2) | 0.8944 |
AFC, antral follicular count; AMH, anti-mullerian hormone; BMI, body mass index; D3, day 3; E2, estradiol; SD, standard deviation
Compared with Wilcoxon test